Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

EEG-based Depth of Anesthesia-monitoring, Effects on Dosage and Cognition

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04529304
Recruitment Status : Recruiting
First Posted : August 27, 2020
Last Update Posted : March 26, 2021
Sponsor:
Information provided by (Responsible Party):
Luis George Romundstad, Oslo University Hospital

Brief Summary:
Depth of anesthesia-monitoring based on EEG changes demands knowledge about the effects of the different anesthetic medications on EEG waveforms. The investigators want to investigate the use of the raw-EEG waveform in addition to indexes (BIS) and EEG spectrogram analyses for depth of anesthesia monitoring. The investigators hypothesize that with the use of this monitoring, anaesthesia providers will be able to better individualize the dosage of anesthetic drugs, and that this will reduce the total consumption of anesthetic medication , thus reducing time to wake-up after surgery. Some studies have indicated that too deep anesthesia, confirmed by "burst-suppression" or isoelectric-EEG , is associated with increased postoperative cognitive dysfunction (POCD). The investigators will therefore assess the patients with the Cambridge Neuropsychological Test Automated Battery tests in mild cognitive impairment (CANTAB-MCI) cognitive function assessment tool.

Condition or disease Intervention/treatment Phase
Postoperative Complications Delayed Emergence From Anesthesia Cognitive Dysfunction Device: Bilateral Bispectral Index and EEG Not Applicable

Detailed Description:

It has been over 80 years since Gibbs et al showed how the electroencephalogram (EEG) systematically changed in concurrence with increasing doses of hypnotic drugs such as penthobarbital and Ether. The study concluded that "Electroencephalography may therefore be of value in controlling depth of anesthesia and sedation". In spite of a solid documentation of the systematic connection between dosing of anesthetic drugs, EEG-patterns and level of sedation/anesthesia , EEG-based DoA has not become a part of standard of care in anesthetic management. There is abundant evidence of how different anesthetic drugs leads to characteristic fluctuations in human brain electrical activity, relating to depth of anesthesia, anesthetic drug of choice, and age . These anesthetic induced fluctuations are readily visible as changes in the patients EEG.

Anesthetic drugs are usually administered in pharmacological models based on a population taking into account their age, weight and height. However, there is a significant difference in how patients respond to these models. In adults there is evidence that the doses needed to achieve consciousness varies with a factor of 2 above and below suggested doses. In under-dosing of anesthetics there is a risk of peroperative awareness . On the other hand there is also evidence that overdosing of anesthetics has harmful effects; children receiving more than 4% Sevoflurane can demonstrate epileptiform activity , and adults overdosing into "burst suppression" during anesthesia has a higher risk of postoperative delirium (POD) and increased occurrence of postoperative cognitive dysfunction (POCD) .

Bispectral Index (BIS) is an algorithm developed by Aspect Medical Systems in 1994, which is based on weighted sums of EEG subparameters to present an index from 0 to 100 for depth of anesthesia, where 100 is wide awake, and 0 is an isoelectric EEG. The BIS target for a deep enough anesthesia is set to be between 40 and 60. The BIS number is often in concurrence with other clinical observations related to anesthetic depth, however there is also an experience of divergence. BIS and other EEG-based indices are programmed from adult cohorts, and cannot be directly trusted in children, or the elderly . There is also an incapability in these preprogrammed indices (BIS and other) to integrate how specific anesthetic drugs affect the EEG, and thenceforth the BIS value. An example of this is how the drug Ketamine induces a specific gamma-frequency in the EEG, which the BIS-index translate as a lighter anesthesia, even though the drug is administered "on top of" an already deep level of anesthesia.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 100 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Two groups with 50 participants in each group. We want to compare one group with visible EEG-monitor with a group where the EEG monitor is invisible to the anesthetic team.
Masking: Triple (Participant, Care Provider, Outcomes Assessor)
Masking Description: Patient is blinded to intervention. Outcome assessoring done by patient/IPAD-solution from CANTAB, patient status assessed by blinded care-provider (nurse)
Primary Purpose: Other
Official Title: EEG-based Depth of Anesthesia-monitoring During General Anesthesia - Effects on Time to Wake-up and Post-operative Cognition
Actual Study Start Date : January 8, 2021
Estimated Primary Completion Date : March 15, 2022
Estimated Study Completion Date : December 20, 2022

Arm Intervention/treatment
Experimental: Visual EEG
Individual dosing of anesthetic medications based on EEG AND other standardized clinical observations (BP, HR)
Device: Bilateral Bispectral Index and EEG
raw-EEG and spectrographic EEG-visualization based on the Medtronic Device "Bilateral BiSpectral Index"

Experimental: Blinded EEG
Individual dosing of anesthetic medications based on standardized clinical observations (BP, HR).
Device: Bilateral Bispectral Index and EEG
raw-EEG and spectrographic EEG-visualization based on the Medtronic Device "Bilateral BiSpectral Index"




Primary Outcome Measures :
  1. EEG-based Depth of anesthesia-monitoring and dosage of anesthetic medications [ Time Frame: 24 hours ]
    Summarizing the total amount of anesthetic drugs used, mg/kg/hr

  2. EEG-based Depth of anesthesia-monitoring and dosage of vasopressor medications during anesthesia [ Time Frame: 24 hours ]
    Summarizing the total amount of vasopressor drugs used, micg/kg/min

  3. EEG-based Depth of anesthesia-monitoring and time to wake-up after surgery [ Time Frame: 24 hours ]
    Time from the end of intravenous infusion of anesthetic - to motoric and verbal response.

  4. Evaluation of cognitive function using CANTAB-MCI [ Time Frame: 1 day preoperatively to 24 hours after wake-up ]
    Baseline assessment 1 day preoperatively, assessment 2-3 hours after wake-up, and 24 hours after wake-up using CANTAB-MCI



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 85 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria

.

Participants are eligible to be included in the study only if all of the following criteria apply:

Age

  1. Participant must be above the age of 18 years , at the time of signing the informed consent.

    Sex

  2. Male and/or female

    Informed Consent

  3. Capable of giving signed informed consent as described in protocol which includes compliance with the requirements and restrictions listed in the informed consent form (ICF) and in the protocol

    Exclusion Criteria

    Participants are excluded from the study if any of the following criteria apply:

  4. Psychiatric disorders
  5. Pregnancy
  6. Breast feeding
  7. Using antiepileptic drugs.
  8. Central neurological disease
  9. Unable to complete baseline CANTAB-test.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04529304


Contacts
Layout table for location contacts
Contact: Anders Aasheim, Master +4748129280 uxanim@ous-hf.no
Contact: Luis G Romundstad, MD, PhD luirom@ous-hf.no

Locations
Layout table for location information
Norway
Oslo University Hospital Recruiting
Oslo, Norway, 0124
Sponsors and Collaborators
Oslo University Hospital
Investigators
Layout table for investigator information
Principal Investigator: Luis G Romundstad, MD, PhD Oslo University Hospital
  Study Documents (Full-Text)

Documents provided by Luis George Romundstad, Oslo University Hospital:
Study Protocol  [PDF] November 14, 2019
Informed Consent Form  [PDF] March 9, 2021

Publications:
Gibbs FA, Gibbs LE, Lennox WG. Effects on the electroencephalogram of certain drugs which influence nervous activity. Arch Intern Med. 1937;60:154-66
Juel, Bjørn Erik; Romundstad, Luis Georg; Kolstad, Frode; Storm, Johan Frederik; Larsson, Pål Gunnar. Changes in EEG captured by Directed Transfer Function is sufficient to accurately classify the state of wakefulness in patients undergoing sevoflurane anesthesia in accordance with the clinician's judgement. FENS; 2018
Juel, Bjørn Erik; Kusztor, Aniko; Nilsen, Andre Sevenius; Farnes, Nadine; Larsson, Pål Gunnar; Romundstad, Luis Georg; Storm, Johan Frederik. Changes in electrophysiological markers of consciousness in response to various anesthetics. Nordic Neuroscience; 2017
Nadine Farnes, Bjørn Erik Juel, André Sevenius Nilsen, Luis Romundstad, Johan Fredrik Storm Increased signal diversity/complexity of spontaneous EEG in humans given sub-anaesthetic doses of ketamine. bioRXiv 2019 508697; doi: https://doi.org/10.1101/508697

Layout table for additonal information
Responsible Party: Luis George Romundstad, Principal Investigator, Medical Doctor, Oslo University Hospital
ClinicalTrials.gov Identifier: NCT04529304    
Other Study ID Numbers: 2019/32173
First Posted: August 27, 2020    Key Record Dates
Last Update Posted: March 26, 2021
Last Verified: March 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Plan Description: Data storage and management will follow GCP and GDPR requirements. Data sharing after end of study will follow the current data sharing policy at Oslo University Hospital. Data set can be made available for journal peer review process.
Supporting Materials: Study Protocol
Statistical Analysis Plan (SAP)
Informed Consent Form (ICF)
Clinical Study Report (CSR)
Analytic Code
Time Frame: After end of study, 2025, and 5 years.
Access Criteria: Access through application to study contactpersons.

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Luis George Romundstad, Oslo University Hospital:
Depth of Anesthesia Monitoring
Post operative cognitive dysfunction (POCD)
Additional relevant MeSH terms:
Layout table for MeSH terms
Postoperative Complications
Delayed Emergence from Anesthesia
Cognitive Dysfunction
Pathologic Processes
Cognition Disorders
Neurocognitive Disorders
Mental Disorders